Søgeresultater - Revathi Ananthakrishnan

The Forces Behind Cell Movement af Revathi Ananthakrishnan, Allen Ehrlicher

Få fuldtekst

Pharmacological modeling and biostatistical analysis of a new drug af Revathi Ananthakrishnan, Philimon Gona

Få fuldtekst

2D (2 Dimensional) TEQR design for Determining the optimal Dose for safety and efficacy af Revathi Ananthakrishnan, Stephanie Green, Daniel Li, Michael LaValley

Få fuldtekst

Extensions of the mTPI and TEQR designs to include non-monotone efficacy in addition to toxicity for optimal dose determination for early phase immunotherapy oncology trials af Revathi Ananthakrishnan, Stephanie Green, Daniel Li, Michael LaValley

Få fuldtekst

Systematic comparison of the statistical operating characteristics of various Phase I oncology designs af Revathi Ananthakrishnan, Stephanie Green, Mark Chang, Gheorghe Doros, Joseph Massaro, Michael LaValley

Få fuldtekst

An overview of the BOIN design and its current extensions for novel early-phase oncology trials af Revathi Ananthakrishnan, Ruitao Lin, Chunsheng He, Yanping Chen, Daniel Li, Michael LaValley

Få fuldtekst

Phase 2 results of lisocabtagene maraleucel in Japanese patients with relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma af Shinichi Makita, Go Yamamoto, Dai Maruyama, Yuki Asano‐Mori, Daisuke Kaji, Revathi Ananthakrishnan, Ken Ogasawara, Lara Stepan, Claudia Schusterbauer, Nils Rettby, Jens Hasskarl, Koji Izutsu

Få fuldtekst

Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study af Daniel J. DeAngelo, Wendy Stock, Anthony S. Stein, Andrei Shustov, Michaela Liedtke, Charles A. Schiffer, Erik Vandendries, Katherine Liau, Revathi Ananthakrishnan, Joseph Boni, A. Douglas Laird, Luke Fostvedt, Hagop M. Kantarjian, Anjali S. Advani

Få fuldtekst